Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2012's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on RPRX
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
Financials
Income Statement
Balance Sheet
Cash Flow Statement
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
REPROS THERAPEUTICS (NQ:RPRX)
Delayed:
15.62
-0.12 (0.76%)
Trade Now!
Previous Close
$15.74
52 Week High
$20.78
Open
$15.72
52 Week Low
$7.30
Day High
$15.83
P/E
N/A
Day Low
$15.14
EPS
$-1.41
Volume
20,000
Friends, Peers and Foes
(?)
:
NTE
,
LMT
,
HLF
,
DOLE
,
GLUU
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
May 16, 2013 11:01 AM
Form 8-K REPROS THERAPEUTICS INC. For: May 16
May 10, 2013 12:08 PM
Form 10-Q REPROS THERAPEUTICS INC. For: Mar 31
May 10, 2013 09:29 AM
Repros Therapeutics, Inc. (RPRX) Posts Q1 Loss of 41c/Share
May 10, 2013 09:25 AM
Form 8-K REPROS THERAPEUTICS INC. For: May 10
May 10, 2013 09:25 AM
Repros Therapeutics Inc.(R) Reports First Quarter 2013 Financial Results
May 2, 2013 01:18 PM
Form 8-K REPROS THERAPEUTICS INC. For: May 02
May 2, 2013 12:59 PM
Repros Reports Second Pivotal Androxal(R) Study Fully Enrolled Ahead of Schedule
Apr 29, 2013 12:09 PM
Form 8-K REPROS THERAPEUTICS INC. For: Apr 29
Apr 29, 2013 12:00 PM
Repros' Proellex(R) in Breast Cancer Phase 2 Study in Collaboration With Northwestern University
Apr 29, 2013 11:45 AM
Form 8-K REPROS THERAPEUTICS INC. For: Apr 29
View All Articles
May 10, 2013 09:29 AM
Repros Therapeutics, Inc. (RPRX) Posts Q1 Loss of 41c/Share
Mar 18, 2013 09:30 AM
Repros Therapeutics, Inc. (RPRX) Posts Wider than Expected Q4 Loss
Nov 13, 2012 04:32 PM
Repros Therapeutics, Inc. (RPRX) Posts Q3 Loss of 30c/Share
Aug 13, 2012 09:26 AM
Repros Therapeutics, Inc. (RPRX) Posts Wider than Expected Q2 Loss of 21c/Share
Mar 27, 2012 09:27 AM
Repros Therapeutics, Inc. (RPRX) Tops Q4 EPS by 6c
Nov 10, 2011 09:26 AM
Repros Therapeutics, Inc. (RPRX) Posts Narrower than Expected Q3 Loss
Aug 9, 2011 09:27 AM
Repros Therapeutics, Inc. (RPRX) Reports Q2 Loss of $0.30
View All Major News
May 10, 2013 09:29 AM
Repros Therapeutics, Inc. (RPRX) Posts Q1 Loss of 41c/Share
Apr 10, 2013 12:27 PM
Repros (RPRX) Receives Two More Patents Covering Androxal Indications
Apr 9, 2013 04:41 PM
Jennison Associates Shows New 16.14% Stake in Repros Therapeutics (RPRX)
Mar 28, 2013 02:09 PM
Unusual 11 Mid-Day Movers 03/28: (RPRX) (LIVE) (PRTS) Higher; (HDSN) (SXE) (GV) Lower
Mar 28, 2013 09:27 AM
StreetInsider.com Pre-Open Movers 03/28: (RPRX) (DECK) (XONE) Higher; (FIVE) (RHT) (GME) Lower (more...)
Mar 28, 2013 06:31 AM
Repros (RPRX) Androxa Meets Primary Endpoints
Mar 18, 2013 09:30 AM
Repros Therapeutics, Inc. (RPRX) Posts Wider than Expected Q4 Loss
Feb 28, 2013 09:27 AM
Repros Therapeutics (RPRX) Granted FDA Type B meeting on Proellex
Feb 21, 2013 01:22 PM
Unusual 11 Mid-Day Movers 02/21: (WH) (PRKR) (RPRX) Higher; (PAY) (SYNC) (GENT) Lower
Feb 21, 2013 09:33 AM
StreetInsider.com Pre-Open Movers 02/21: (PRKR) (RPRX) (BRY) Higher; (PAY) (TSLA) (WLT) Lower (more...)
View All Reports
May 10, 2013 09:25 AM
Repros Therapeutics Inc.(R) Reports First Quarter 2013 Financial Results
May 2, 2013 12:59 PM
Repros Reports Second Pivotal Androxal(R) Study Fully Enrolled Ahead of Schedule
Apr 29, 2013 12:00 PM
Repros' Proellex(R) in Breast Cancer Phase 2 Study in Collaboration With Northwestern University
Apr 29, 2013 11:33 AM
Repros to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
Apr 10, 2013 12:22 PM
Repros Reports Issuance of Two Additional U.S. Androxal(R) Patents
Mar 27, 2013 08:00 PM
Repros Reports Both Primary Endpoints Successfully Met in First Pivotal Study of Androxal(R)
Mar 25, 2013 10:04 AM
American Urological Association (AUA) Accepts Androxal(R) Versus Topical Gel Comparative Study for Podium Presentation at Annual Meeting
View All Press Releases
May 16, 2013 11:01 AM
Form 8-K REPROS THERAPEUTICS INC. For: May 16
May 10, 2013 12:08 PM
Form 10-Q REPROS THERAPEUTICS INC. For: Mar 31
May 10, 2013 09:25 AM
Form 8-K REPROS THERAPEUTICS INC. For: May 10
May 2, 2013 01:18 PM
Form 8-K REPROS THERAPEUTICS INC. For: May 02
Apr 29, 2013 12:09 PM
Form 8-K REPROS THERAPEUTICS INC. For: Apr 29
Apr 29, 2013 11:45 AM
Form 8-K REPROS THERAPEUTICS INC. For: Apr 29
Apr 10, 2013 03:56 PM
Form SC 13G REPROS THERAPEUTICS INC. Filed by: PRUDENTIAL FINANCIAL INC
Apr 10, 2013 12:42 PM
Form 8-K REPROS THERAPEUTICS INC. For: Apr 10
Apr 9, 2013 04:36 PM
Form SC 13G REPROS THERAPEUTICS INC. Filed by: JENNISON ASSOCIATES LLC
Apr 8, 2013 04:05 PM
Form SC 13G REPROS THERAPEUTICS INC. Filed by: Partner Fund Management, L.P.
View All Filings
Entities mentioned with
RPRX
Unusual 11 Mid-Day Movers
|
View Related Stories »
Earnings
|
View Related Stories »
Morning Movers
|
View Related Stories »
Citi
|
View Related Stories »
JPMorgan
|
View Related Stories »
Roth Capital
|
View Related Stories »
Merriman Curhan Ford
|
View Related Stories »
Ladenburg Thalmann Financial Services
|
View Related Stories »
13G
|
View Related Stories »
Cerberus Capital
|
View Related Stories »
Bank of America
|
View Related Stories »
Bankruptcy
|
View Related Stories »
Robert W Baird
|
View Related Stories »
S3
|
View Related Stories »
American Technology Research
|
View Related Stories »
Dividend
|
View Related Stories »
Merrill Lynch
|
View Related Stories »
Silverleaf Resorts/Cerberus
|
View Related Stories »
Piper Jaffray
|
View Related Stories »
Morgan Joseph
|
View Related Stories »
13D
|
View Related Stories »
Wedbush Morgan
|
View Related Stories »
UBS
|
View Related Stories »
William Blair
|
View Related Stories »
Tesla
|
View Related Stories »
Show More...
View All Entities